• MOF Nanoparticles for BBB-Crossing Sononeuromodulation

  2026-08-24

  The reference study presents ultrasound-activated piezoelectric nanoparticles based on a metal-organic framework for non-invasive, targeted neuromodulation in epilepsy. By combining brain-targeting ligands with platinum nanoclusters, the platform is designed to cross the blood–brain barrier, generate local electrical signals, and regulate both neuronal activity and the pathological microenvironment.

• Rosiglitazone Workflows for Adipose Metabolism

  2026-08-23

  Build reproducible Rosiglitazone and Brl-49653 experiments that separate PPARγ-driven adipogenesis from beige-fat thermogenesis and insulin-response phenotypes. The workflow combines controlled dosing, orthogonal metabolic readouts, and the SETD7–Adcy7–Sirt1–CREB1 framework to improve interpretation in type II diabetes research.

• Dhcr7 Knockout Grass Carp and GCRV Resistance

  2026-08-22

  A 2026 Aquaculture Reports study used CRISPR/Cas9 to disrupt dhcr7 in grass carp and demonstrated substantially improved resistance to GCRV-II challenge. The findings connect sterol metabolism with IRF3-associated antiviral immunity while preserving measured growth and muscle traits, providing an in vivo target for disease-resistant aquaculture breeding.

• Pazopanib (GW-786034): RTK Inhibition Guide

  2026-08-21

  Pazopanib, also called GW-786034, is an orally active multi-targeted receptor tyrosine kinase inhibitor used in cancer research. Its reported VEGFR, PDGFR, FGFR, c-Kit, and c-Fms activity supports studies of angiogenesis inhibition, VEGF signaling, and tumor growth suppression, while ATRX-deficient glioma data provide a rationale for biomarker-defined experiments rather than a clinical efficacy claim.

• β-Elemene Inhibits Adipogenesis via AMPK

  2026-08-20

  The reference study shows that β-Elemene reduces MDI-induced lipid accumulation and improves glucose consumption in differentiated and insulin-resistant 3T3-L1 adipocytes. Its central contribution is linking these effects to restoration or activation of AMPK signaling, providing a mechanistic foundation for studying Levo-β-elemene in cellular obesity and metabolic research.

• Dihydroethidium Workflow for Superoxide Assays

  2026-08-20

  Build a practical Dihydroethidium workflow for live-cell superoxide detection, with assay choices tailored to ischemia–reperfusion, mitochondrial injury, apoptosis research, and cardiovascular disease research. This guide emphasizes controls, quantitative imaging, and troubleshooting so red fluorescence becomes interpretable biological evidence rather than a standalone signal.

• BKT140 (BL-8040) CXCR4 Assay Workflows

  2026-08-19

  Build reproducible CXCR4 studies with BKT140 (BL-8040), from chemotaxis and apoptosis assays to hematopoietic stem cell mobilization workflows. This guide separates literature-backed biology from practical starting conditions and shows how to troubleshoot solubility, receptor expression, and assay variability.

• Perphenazine Workflows for Neuroimmune Research

  2026-08-19

  Perphenazine is a dopamine D2 receptor antagonist that supports practical workflows spanning neuronal mitochondrial injury, receptor pharmacology, opioid tolerance suppression, and host-directed antibacterial research. This guide translates its documented activity into assay-ready setup, controls, optimization strategies, and cross-domain interpretation.

• Indometacin Sodium: Assay Workflows & Applications

  2026-08-18

  Indometacin Sodium supports more than conventional COX inhibition: it enables coordinated inflammation, pancreatic stellate cell, oligodendrocyte, and remyelination studies. This practical guide connects concentration selection, pathway-specific readouts, formulation, and troubleshooting for reproducible anti-inflammatory research.

• Hexetidine (NSC-17764) Research Workflows

  2026-08-18

  Build reproducible antimicrobial, oral biofilm, and mouth-rinse experiments around Hexetidine (NSC-17764), with concentration ranges matched to the biological model. The workflow distinguishes planktonic MIC testing from biofilm inhibition and clinical translation while addressing solvent, exposure-time, and comparator effects.

• A-1155463: Mapping Functional BCL-XL Dependence

  2026-08-17

  The selective BCL-XL inhibitor A-1155463 offers a powerful way to distinguish target expression from true apoptotic dependence. This article connects its pharmacology with glioblastoma evidence and shows how model selection, orthogonal assays, and platelet liability improve interpretation.

• M1R/B6R Bispecific Antibodies for Orthopoxvirus Protection

  2026-08-17

  The reference study maps neutralizing monoclonal antibodies against the mpox virus antigens M1R and B6R and uses those findings to guide antibody-cocktail and bispecific designs. Its strongest translational result is that a VH-CH1 switch region-inserting bispecific format improved protection against vaccinia virus in mice, while also defining important constraints for future orthopoxvirus antibody development.

• OSMI-1 for O-GlcNAc Transferase Inhibition

  2026-08-16

  OSMI-1 provides a cell-permeable way to lower O-GlcNAcylation and test OGT-dependent mechanisms in trophoblast, ferroptosis, and broader stress models. This guide converts its biochemical potency, cytotoxicity profile, and solubility constraints into practical dosing, validation, and troubleshooting workflows.

• Procainamide Reduces Cisplatin Hepatotoxicity in Rats

  2026-08-15

  The reference study showed that procainamide hydrochloride reduced biochemical and histological evidence of cisplatin-associated liver injury in rats while changing hepatic platinum distribution and platinum–DNA interactions. Its main innovation was to connect hepatoprotection with altered platinum handling and possible formation of a less toxic platinum species, although the findings remain preclinical and mechanistically provisional.

• U 46619 Workflows for Platelet and Vascular Research

  2026-08-15

  U 46619 provides a controlled way to activate TP receptors across platelet, vascular, renal, and hypertension models. This practical guide connects concentration-response design, time-resolved readouts, and translational assay logic while highlighting storage, solvent, and interpretation safeguards.

452 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page